image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k |
|---|---|---|
c45888e7b2590dba0193e2b2619af4ad56822631065d7cf56417e68002069a9f.png | complex | <table><tr><td rowspan="2"></td><td colspan="2">RFS</td><td colspan="2">OS</td></tr><tr><td>HR (95%CI)</td><td><i>P</i> value</td><td>HR (95%CI)</td><td><i>P</i> value</td></tr><tr><td>Univariate analysis</td><td></td><td></td><td></td><td></td></tr><tr><td>Age, yrs (<50 vs. ≥50)</td><td>0.994 (0.973-1.015)</t... |
4106c5e87e5fdfe1850917365168cdd6aff6fb9489db2705658c1760551caee1.png | simple | <table><tr><td>Language</td><td>Number of Manual signs</td><td>Number of mouth gestures</td><td>% of signs accompanied by mouth gestures</td><td>Number of mouthings</td><td>% of signs accompanied by mouthings</td></tr><tr><td>British Sign Language</td><td>1552</td><td>539</td><td>35</td><td>560</td><td>36</td></tr><tr>... |
f65229e20db59ceedbcdd050cc592e665cfc4d92cb5139005ebe075827329402.png | simple | <table><tr><td></td><td>RA control</td><td>MTX group</td><td>TAC group</td><td>TAC + MTX group</td></tr><tr><td></td><td><i>n</i> = 35</td><td><i>n</i> = 55</td><td><i>n</i> = 29</td><td><i>n</i> = 14</td></tr><tr><td>Male/female</td><td>12/23</td><td>11/44</td><td>9/20</td><td>1/13</td></tr><tr><td>Age in years, mean ... |
354f0e0bb29a7a0047b5e7c4052300af514f7c17584816d1dbe6a12ac48f3145.png | complex | <table><tr><td></td><td colspan="3">Associative memory training group</td><td colspan="3">Active control group</td></tr><tr><td></td><td>Pre training <i>M</i> (<i>SD</i>)</td><td>Post training <i>M</i> (<i>SD</i>)</td><td>Effect size</td><td>Pre training <i>M</i> (<i>SD</i>)</td><td>Post training <i>M</i> (<i>SD</i>)</... |
d1eac19ff895bd714b687f1c9f6f944ec76c3153b4d7c7de599a3765c2c1612f.png | complex | <table><tr><td> </td><td colspan="3">IC<sub>50</sub> (μM)<sup>a</sup></td></tr><tr><td>Compound</td><td>HCT-116</td><td>HepG-2</td><td>MCF-7</td></tr><tr><td>6a</td><td>>100</td><td>>100</td><td>>100</td></tr><tr><td>6b</td><td>>100</td><td>94.62 ± 6.93</td><td>>100</td></tr><tr><td>6c</td><td>... |
8b4c8800a092ef1e608d875754cdafc8888ceac7861b38129888df563c445bc2.png | simple | <table><tr><td>GO term ID</td><td>Functional area (GO term of category biological process)</td><td>No. of genes</td></tr><tr><td>GO:0033555</td><td>Multicellular organismal response to stress</td><td>2</td></tr><tr><td>GO:0070997</td><td>Neuron death</td><td>3</td></tr><tr><td>GO:0050877</td><td>Neurological system pro... |
b2e2493aea1f7e0a4189517143349a599225dd09722cc86298b6be38ecac6c2a.png | simple | <table><tr><td>Temperature (°C)</td><td>Activity (U/mL)±SD</td></tr><tr><td>30</td><td>0.073148±0.000327</td></tr><tr><td>35</td><td>0.154167±0.000655</td></tr><tr><td>40</td><td>0.078241±0.000982</td></tr><tr><td>45</td><td>0.037963±0.000327</td></tr></table> |
946dcfe7c14157228f75cd96ee858d62574e43490bf44d1f178530a9fdde5fb8.png | complex | <table><tr><td>Outcome over the last three months</td><td>ControlN=301</td><td>Brief adviceN=291</td><td>Coefficient/OR*95% CI</td></tr><tr><td colspan="4">Weekly alcohol consumption (units)</td></tr><tr><td> Mean (SD)</td><td>20.3 (16.6)</td><td>18.1 (15.6)</td><td>−2.33</td></tr><tr><td> Median (IQR)</td><td>15... |
0a6aa60a1ed6e75a990690dd4830d2c7e684906fb212873798e3f04c185514c3.png | complex | <table><tr><td>Conditions</td><td>Reactor 1</td><td>Reactor 2</td></tr><tr><td>Carrier</td><td>Corncob</td><td>Concrete block</td></tr><tr><td rowspan="3">External carbon</td><td rowspan="3">No</td><td>Phase 1: no </td></tr><tr><td>Phase 2: yes (C/N = 2.5)</td></tr><tr><td>Phase 3: yes (C/N = 3.5)</td></tr><tr><td rows... |
45da4bbf618cbaa2f3edbc1ffd1589fa178d4bef783302c0476a7af53dd29041.png | simple | <table><tr><td>Parameters</td><td>Chronic HBV patients</td><td>Health volunteers</td></tr><tr><td>No.</td><td>22</td><td> 20</td></tr><tr><td>Age (years)</td><td></td><td></td></tr><tr><td> Mean ± SD</td><td>45.9 ± 8.1</td><td>38.5 ± 11.8*</td></tr><tr><td> Median</td><td>46</td><td>36.5</td></tr><tr><td... |
6bc124ac6bf304374a6d8901d06b6da18679e7a58430c16f5013155ea54a08cd.png | complex | <table><tr><td>Program</td><td colspan="2">Nucleotide</td><td colspan="2">Exon</td><td colspan="2">Gene</td></tr><tr><td></td><td>Sensitivity</td><td>Specificity</td><td>Sensitivity</td><td>Sensitivity</td><td>Specificity</td><td>Sensitivity</td></tr><tr><td>Pair-wise GeneMapper</td><td>99.95</td><td>99.93</td><td>91.3... |
5239fd4eaea963b7209f19ce1aeed98c5cba004accc82ba8ba3a7686654c7aff.png | simple | <table><tr><td>Methods</td><td>TP</td><td>FP</td><td>FN</td></tr><tr><td>[24, 25]</td><td>93.4%</td><td>0.18%</td><td>6.6%</td></tr><tr><td>Proposed</td><td>96.8%</td><td>0.12%</td><td>3.2%</td></tr></table> |
d05cd1d6c320a5ef91ca5c1a34c8a48a6242de4027b63787d00e2c72ec696cb2.png | simple | <table><tr><td>Subject </td><td> 1 </td><td> 2 </td><td> 3 </td><td> 4 </td><td> 5 </td><td> 6 </td><td> 7 </td><td> 8 </td><td> 9 </td><td> 10 </td></tr><tr><td>Accuracy</td><td> 88.23%</td><td> 92.10%</td><td> 78.57%</td><td> 86.53%</td><td> 77.77%</td><td> 67.39%</td><td> 68.18%</td><td> 80.35%</td><td> 69.04%</td><... |
575463b48874c8a11d172fd2df4957dd962356e55e1ba6c06bf2086d43b7f315.png | simple | <table><tr><td>Variables </td><td>IS (<i>n</i> = 198)</td><td>Controls (<i>n</i> = 236)</td><td><i>P</i> value</td></tr><tr><td>Age (years, mean ± SD)</td><td>57.2 ± 11.8 </td><td>55.4 ± 11.7</td><td>0.12</td></tr><tr><td>Gender (%)</td><td> </td><td> </td><td> </td></tr><tr><td>Male </td><td>122 (61.6)<... |
16f2d81a69930da3b889f46fe17cadd80110245ef23f62abecc802a6048ee334.png | complex | <table><tr><td rowspan="3"></td><td colspan="4">Mbeya</td><td colspan="4">Mtwara</td><td colspan="4">Mwanza</td></tr><tr><td colspan="2">Health facilities (N = 18)</td><td colspan="2">Non-HF AM providers (N = 38)<sup>a</sup></td><td colspan="2">Health facilities (N = 16)</td><td colspan="2">Non-HF AM providers (N = 21)... |
ee046305565df75238f91b7ae6eb15575cbe2a23d8f663d1108e31c9b98d0b40.png | simple | <table><tr><td>Benign prostatic hyperplasia patients</td><td><i>n</i> = 49</td></tr><tr><td>IPSS Score (Barry et al., 1992)</td><td></td></tr><tr><td>0–7</td><td>0</td></tr><tr><td>8–19</td><td>24</td></tr><tr><td>20–35</td><td>17</td></tr><tr><td>Unknown</td><td>8</td></tr><tr><td>Prostate cancer pat... |
bb2edc7b7c8f49ea276dce674bf2ceacd054c2efb65287ccff61a7f5d1bae080.png | complex | <table><tr><td>Antibiotic<sup>a</sup></td><td colspan="8">Minimal inhibitory concentration (μg/ml)<sup>b</sup></td></tr><tr><td></td><td colspan="2">NVT2001S</td><td colspan="2">Δ<i>ompK35</i></td><td colspan="2">Δ<i>ompK36</i></td><td colspan="2">Δ<i>ompK35/36</i></td></tr><tr><td></td><td>NO<sup>c... |
3a756bdd634c56a82f51ab460ce9441fba3fbf441349ea844a4c6c5f435c54c5.png | complex | <table><tr><td></td><td>Radiographic OA</td><td>Pain</td><td>Mean</td><td>SE</td><td colspan="2">95% CI of the mean</td><td><i>P-</i>value</td><td>95% CI for difference</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td>Lower</td><td>Upper</td><td></td><td></td></tr><tr><td>sC2C</td><td>K/L 1</td><td>-</td><... |
f030540814dbaabd6df8934fc3b0f5af231fa6c7af8f862ba8d7dceab62952c4.png | complex | <table><tr><td></td><td colspan="2">Swab</td><td>N</td></tr><tr><td>Score Card</td><td>Bacterial</td><td>Viral</td><td></td></tr><tr><td>Positive</td><td>21</td><td>19</td><td>40</td></tr><tr><td></td><td>(True Positive)</td><td>(False Positive)</td><td></td></tr><tr><td>Negative</td><td>2</td><td>40</td><td>42</td></t... |
c6b192c7d0befdbab33337a73ed65a0af775d3200fc6ae42528d2671222bed41.png | complex | <table><tr><td colspan="2">Microbiology of prosthetic infection (1 day- > 1 year) after haernia or ventral mesh repair</td></tr><tr><td><i>Staphylococcus aureus</i></td><td>50–60 %</td></tr><tr><td><i>Staphylococcus spp</i></td><td>10–20 %</td></tr><tr><td><i>Enterococcus spp</i></td><td>10–20 %</t... |
2b9df26811d7889793c474048241c13f9b5b6df5d1c14e2a8da292e30816b713.png | complex | <table><tr><td rowspan="2"></td><td colspan="2">Richest Quintile</td><td colspan="2">Poorest Quintile</td><td colspan="3">Difference</td><td colspan="3">Ratio</td></tr><tr><td>Earliest Survey</td><td>Latest Survey</td><td>Earliest Survey</td><td>Latest Survey</td><td>Earliest Survey</td><td>Latest Survey</td><td><i>p</... |
cd7e1a4f11c12bb4dadddbff46bd0309363e0b914d6676bbaecfeaa3b89ec3a5.png | complex | <table><tr><td>Item #</td><td>VII. Monitoring, Evaluation, and Information Systems</td><td colspan="2">Burkina Faso</td><td colspan="2">Dominican Republic—national</td><td colspan="2">Dominican Republic—subnational</td><td colspan="2">Ghana</td><td colspan="2">Mali</td><td colspan="2">Total</td></tr><tr><td... |
baf2727aea2f429bb787f7fd8f04fdf62ac0624af6e6bb8fa7789fe6e10f2c83.png | complex | <table><tr><td>Variables</td><td>Results</td></tr><tr><td>Male, n (%)</td><td>20 (48.8)</td></tr><tr><td>Age, years</td><td>49.39 ± 0.82</td></tr><tr><td colspan="2">Position, n (%)</td></tr><tr><td> President of hospital</td><td>1 (2.4)</td></tr><tr><td> Vice president of hospital</td><td>2 (4.9)</td></tr><tr><td... |
172b4243176396b7dc7f2495c767b163b0563512daaff65c85b79f8899b2e62e.png | simple | <table><tr><td>Measure</td><td>Content validity </td><td>Construct validity</td><td>Internal consistency</td><td>Interrater agreement </td><td>Reliability </td><td>Responsiveness</td></tr><tr><td>Cosmesis visual analog scale (VAS)</td><td>?</td><td>?</td><td>?</td><td>?</td><td>?</td><td>?</td></tr><tr><td>Disabilities... |
b667e5c999bbba741432a022d3c6f22a2dd4756fc695d026e783dd0e9eaf3640.png | simple | <table><tr><td>Variable</td><td>Patients (n)</td><td>Number of patients (IMP-Expression) (%)</td><td></td><td></td><td></td><td>p-Value (linear by linear)</td></tr><tr><td></td><td></td><td>0</td><td>1</td><td>2</td><td>3</td><td></td></tr><tr><td>pT-status</td><td></td><td></td><td></td><td></td><td></td><td>0.5</td><... |
ecb9ba1fcab5cb1a9549b26786c0c119d81a4a5e738f8a1014e19ac04ea49603.png | simple | <table><tr><td>NAbs</td><td>OSEs</td><td>Properties/Functions</td></tr><tr><td>T15/E06</td><td>PC head-group of oxidized phosphatidylcholine</td><td>Blockage of OxLDL uptake by macrophages (Horkko et al., 1999; Binder et al., 2003)Binding to OxLDL and apoptotic cells and atherosclerotic lesions (Palinski et al., 1996; ... |
c338cbe3b4e8bc3d74875cbfc6f31af3760637ad75cd99e5ebab0134845fbd62.png | simple | <table><tr><td>Prevalence (%) in Control arm</td><td>Reduction in Prevalence due to each intervention (ECF or HH) individually</td><td>Prevalence (%) in ECF or HH arm</td><td>Overall number of communities needed (equally split into 4 arms)</td></tr><tr><td>k = 0.15</td><td></td><td></td><td></td></tr><tr><td>0.6</td><t... |
b773b969a6ef9d6daa14bcce250110dd2f0cd7e82d4f5a9e6f0630223e1ca489.png | simple | <table><tr><td>Independent Variables **</td><td>Intercept</td><td>US-Born</td><td>SE</td><td><i>p</i> value</td></tr><tr><td>α-Carotene </td><td>4.59</td><td>−1.03</td><td>0.21</td><td><0.0001</td></tr><tr><td>β-Carotene </td><td>18.13</td><td>−3.27</td><td>0.84</td><td>0.0001</td></tr><tr><td>... |
5a9cc02acb964011664f085cdf00dcd083600e612a8401ed371d9f651e3e7408.png | complex | <table><tr><td rowspan="2">Adverse events</td><td colspan="2">All treated patients (<i>n</i> = 42)</td></tr><tr><td>Any grade</td><td>Grade 3–5<sup>a</sup></td></tr><tr><td colspan="3">Skin and subcutaneous tissue disorders</td></tr><tr><td> Pruritus</td><td>6 (14.3)</td><td>0</td></tr><tr><td> Maculopapular rash... |
164c4dafdf8b26b5c512816bdf3870495e45c5b0b7355d719fde1e35dd705a08.png | simple | <table><tr><td>Probe/Chromosome</td><td><i>S.ita-</i>Y1(c)</td><td>Qing 9(c)</td><td><i>S.adh-</i>W94(c)</td><td><i>S.lac-</i>W74(c)</td><td><i>S.par-</i>W79(c)</td><td><i>S.pal-</i>N193(c)</td><td><i>S.gla-</i>W12(c)</td><td><i>S. are-</i>N196(c)</td><td><i>S. pli-</i>N195(c)</td></tr><tr><td>S. vir-Q24(p)</td><td><i>... |
e7037d4a0505ba914e98780f820f9dfdfdd01c66de60ee530ae4b8138520b073.png | simple | <table><tr><td>Variables</td><td>No. of patients (<i>n</i> = 74)</td><td>Percentage (%)</td></tr><tr><td>Gender</td><td></td><td></td></tr><tr><td>Male</td><td>32</td><td>43.24</td></tr><tr><td>Female</td><td>42</td><td>56.76</td></tr><tr><td>Age (years)</td><td>54.36 ± 13.13</td><td>-</td></tr><tr><td>Hospital st... |
44321f3c4174eff0a7e91b4f305e33fd52ac8c479540304dbcd6101960a40a4d.png | complex | <table><tr><td></td><td>Placebo</td><td>1-day</td><td>3-day</td><td>7-day</td></tr><tr><td>Number of subjects</td><td>26</td><td>26</td><td>27</td><td>27</td></tr><tr><td>Age (years)*</td><td>41.0 ± 2.2</td><td>41.9 ± 2.2</td><td>38.5 ± 1.7</td><td>36.5 ± 1.4</td></tr><tr><td colspan="5">Gender</td>... |
818769e98e97e199ab44182f89a4ade6cc9587df0ed36297988c6ab6c85a54ed.png | complex | <table><tr><td colspan="2"></td><td>YoudenCut-off</td><td>Sensitivity (%)</td><td>Specificity (%)</td><td>AUC</td><td>95% CI</td><td><i>P</i>-value</td></tr><tr><td rowspan="4"><i>Rest</i></td><td>GLS (%)</td><td>>−18.55</td><td> 77.27</td><td>68.18</td><td>0.72</td><td>0.56–0.87</td><td> 0.006</td></tr>... |
4efc6635768fa1a0e25674ceb66a8b3584515dde1d494ec230c279c0fb09841b.png | simple | <table><tr><td>Morbidity</td><td>Measuring instrument</td><td>Data source</td></tr><tr><td>Diagnoses</td><td>ICD-10 codes</td><td>chart review</td></tr><tr><td>Diseases</td><td>self-developed questionnaire</td><td>GP interview</td></tr><tr><td></td><td>self-developed questionnaire</td><td>patient interview</td></tr><tr... |
5de66913410bae57fe4f63c9d0bf1109faf8b37e3dab60672bc3ccf5a270789e.png | complex | <table><tr><td> </td><td><i>ß</i></td><td>SE (<i>ß</i>)</td><td>Stand. <i>ß</i></td><td>T</td><td><i>p</i></td></tr><tr><td colspan="6">Annual fastest men</td></tr><tr><td>6 hrs</td><td>0.015</td><td>0.130</td><td>0.023</td><td>0.114</td><td>0.910</td></tr><tr><td>12 hrs</td><td>-0.023</td><td>0.155</td>... |
b0dfc63442099e9d3b64b45d64e75ac7fea4d2b5b98009c960dceb4404268ddd.png | complex | <table><tr><td></td><td>Male</td><td>Female</td><td>Age < 55 years</td><td>Age ≥ 55 years</td><td>OA</td><td>RA</td><td>THR</td><td>TKR</td></tr><tr><td colspan="9">Core domains</td></tr><tr><td rowspan="2"> Joint pain</td><td>8 (7–9)</td><td>9 (8–9)</td><td>9 (7–9)</td><td>9 (8–9)</td>... |
bdf887bfe36d2c5bc4b14afe78250c315964cf0f80af4ba3879cfc3a35c925b2.png | complex | <table><tr><td></td><td>No. households without bed nets (%, 95 % CI)</td><td>No. households with untreated bed nets (%, 95 % CI)</td><td>No. households with expired ITNs/LLINs (%, 95 % CI)</td><td>No. households with ITNs/LLINs (%, 95 % CI)</td></tr><tr><td colspan="5">Sex of household head</td></tr><tr><td>Male (<i>n<... |
f3f517c724cdececaae0503ca060fb92607a558206a57b263bf5b2622c78487c.png | complex | <table><tr><td rowspan="2">Noise receiving point</td><td colspan="4">Noise at boundary of substation</td></tr><tr><td>Plan A</td><td>Plan B</td><td>Plan C</td><td>Plan D</td></tr><tr><td>Point 1</td><td>62.1</td><td>62</td><td>48.5</td><td>47</td></tr><tr><td>Point 2</td><td>57.5</td><td>53.5</td><td>55.5</td><td>41.9<... |
a402f2e4d94ac6cedf0c439d357655ff2294c80b1defa7687d717592816c0e28.png | complex | <table><tr><td>Characteristics</td><td>Awareness (n)</td><td><i>x</i><sup>2</sup></td><td><i>P</i> – value</td><td>Percentage %</td></tr><tr><td colspan="5">Sex</td></tr><tr><td>Male</td><td>51</td><td>1.03</td><td>0.31</td><td>43.2</td></tr><tr><td>Female</td><td>67</td><td></td><td></td><td>56.8</td></tr><tr><t... |
ee310a1e0eaf6bbd1cd24a6b01fcd94b345e1f955ad9ead7775b3acf4b6e56de.png | simple | <table><tr><td>Causes of death<sup>a</sup></td><td>All patients (<i>n</i> = 345)</td><td>Patients with primary GF (<i>n</i> = 22)</td><td>Patients without primary GF (<i>n</i> = 323)</td></tr><tr><td>Relapse</td><td>18 (5.2 %)</td><td>1 (4.5 %)</td><td>17 (5.3 %)</td></tr><tr><td>Infections</td><td>27 (7.8 %)</td><td>8... |
3efc27033fd45c7a61cd6bc1dd4d5dc0f556f95547d510ca6de0bb2300120557.png | simple | <table><tr><td>Primer (F: forward, R: reverse)</td><td>Sequence (5′–3′)</td><td>Product size (base pairs)</td><td>Description</td></tr><tr><td><i>fimA</i>-F</td><td>CTAAATCCGCCGATCAAA</td><td>193</td><td>Type-1 fimbrial gene</td></tr><tr><td><i>fimA</i>-R</td><td>GAGGAGACAGCCAGCAAA</td><td>193</td><td... |
438d14b914035d9483b8e35a0508a7ccd54a73c41ca158cb5b449acd4ee52e0a.png | simple | <table><tr><td>Stages</td><td>R1</td><td>R2</td><td>R3</td><td>R4</td><td>R5</td><td>R6</td><td>R7</td></tr><tr><td>Pre-processing of each view (normal calculation, format conversion, <i>etc.</i>)</td><td>5 m</td><td>4m30s</td><td>4m</td><td>3m30s</td><td>3m</td><td>2m30s</td><td>2m</td></tr><tr><td>Definition of the o... |
498d670cac0fbbf83572f683577407b28f1b148118ec835224e83f8b4c415b46.png | complex | <table><tr><td colspan="3">Virus</td><td colspan="4">EV71</td><td colspan="4">CV-A16</td><td colspan="4">CV-A6</td><td colspan="4">EV71and CV-A16 co-infection</td><td colspan="4">Untyped EV</td></tr><tr><td colspan="2"></td><td>V-P</td><td>P</td><td>Cons ratio (%)</td><td>M</td><td>F</td><td>P</td><td>Cons ratio (%)</t... |
55b56829ff9bbf305bac187e4a3621f682f0f1afa20008438f3237458e54a5d0.png | simple | <table><tr><td>Allocation concealment methods</td><td>Number of trials (%)</td></tr><tr><td>Unclear/not reported</td><td>282 (71.76)</td></tr><tr><td>Central concealment</td><td>21 (5.34)</td></tr><tr><td>Sequentially numbered, opaque and sealed envelopes</td><td>24 (6.11)</td></tr><tr><td>Unsafe envelopes</td><td>15 (... |
2c17a935972f805fa3a4e42856dc3beda4411578a2c667dcb919552ae6dff34e.png | complex | <table><tr><td>Caffeine source</td><td colspan="3">Birth weight (Marsal)</td><td colspan="3">Birth weight (Skjaerven)</td><td colspan="3">Birth weight (Gardosi)</td></tr><tr><td></td><td>β (g)</td><td>95% CI</td><td><i>P </i>value<sup>a</sup></td><td>β (g)</td><td>95% CI</td><td><i>P </i>value<sup>a</sup></td... |
2264ec9d658fac97bbf8e43ede8168f78a2f7e26455abb23e716f3bef1e032f6.png | simple | <table><tr><td>Group division (n)</td><td>Mean alpha angle ± SD</td></tr><tr><td>Semiprofessional group (14)</td><td>55.16 ± 6.58°</td></tr><tr><td>Amateur group (14)</td><td>51.65 ± 4.43°</td></tr><tr><td><i>P</i> value</td><td>0.11</td></tr></table> |
636cb9c86bf77ab6399f1aa6566cfe93ab8e62538b50e9da8e41d21557d65737.png | complex | <table><tr><td>Characteristics/Outcome</td><td>Group I</td><td>Group II</td><td>Group I and II</td></tr><tr><td></td><td>600/750 mg ≥30 kg</td><td>300/375 mg 15 – 30 kg</td><td>All Participants</td></tr><tr><td>Number enrolled</td><td>208</td><td>238</td><td>446</td></tr><tr><td>Number completed</td><td>203... |
0794a94b2f1315d94689ee5cd94578e24053beee1c068c071886dc02eb9bd552.png | simple | <table><tr><td> </td><td>USDA</td><td>F009</td><td>G002</td><td>W106</td></tr><tr><td>USDA</td><td> </td><td>185</td><td>183</td><td>51</td></tr><tr><td>F009</td><td>24</td><td> </td><td>203</td><td>184</td></tr><tr><td>G002</td><td>51</td><td>45</td><td> </td><td>176</td></tr><tr><td>W106</td><td>16</td><td>28</td><td... |
598601c490eba7dec3b5b09fc4c1977acaf46b39a5f5c4858f56fb3b83da3f9d.png | simple | <table><tr><td>GS Method</td><td>F/B</td><td>S/F</td><td>K/F</td><td>M/F</td><td>O/P</td><td>O/DM</td><td>Mean</td></tr><tr><td>RR-BLUP</td><td>0.28</td><td>0.25</td><td>0.17</td><td>0.14</td><td>0.17</td><td>0.14</td><td>0.19</td></tr><tr><td>BA</td><td>0.29</td><td>0.24</td><td>0.19</td><td>0.15</td><td>0.17</td><td>... |
4fc689a3f5bb8e45fa6bbfce0f905b290275ecca6d85ff622d0771788ea13784.png | complex | <table><tr><td colspan="2">HAS2</td><td colspan="2">ZEISS Objective</td></tr><tr><td>Parameter</td><td>Value</td><td>Parameter</td><td>Value</td></tr><tr><td>Overall dimensions </td><td>30 mm × 30 mm </td><td>f</td><td>85 mm</td></tr><tr><td>Image sensor format</td><td>1024 × 1024 pixels</td><td>F/#</td><td>1... |
f6d761b4247902d0344865d1af5c5400acab8d4f74c75246cb546d59097f7edd.png | complex | <table><tr><td>Outcome measures</td><td>Baseline (<i>n</i> = 15)</td><td>Post-trial (<i>n</i> = 15)</td><td><i>P</i> value</td></tr><tr><td colspan="4">CWIT</td></tr><tr><td> Color naming</td><td>48.35 ± 18.86</td><td>52.35 ± 22.57</td><td>0.0999</td></tr><tr><td> Word reading</td><td>34.00 ± 10.97</td><... |
5a5d3edf0ca4f0a547920bf796f7223ff4742f11718b3afab050f2def63a51d2.png | complex | <table><tr><td colspan="7">ANOVA</td></tr><tr><td>Source of variation</td><td>SS</td><td>df</td><td>MS</td><td><i>F</i></td><td><i>P</i> value</td><td><i>F</i> crit </td></tr><tr><td>Effect of biofilm type*</td><td>0.7377</td><td>1</td><td>0.7377</td><td>0.1692</td><td>0.6837</td><td>4.170877</td></tr><tr><td>Effect of... |
407ba5b688bd62dd10199893ab3499232c9497220634d1464769286a21bc00d1.png | complex | <table><tr><td></td><td>Early-onset Disease (<i>n</i> = 22)</td><td>Late-onset Disease (<i>n</i> = 46)</td><td>Total<sup>a</sup>(<i>n</i> = 68)</td></tr><tr><td>Sex (female/male)</td><td>6/16</td><td>25/21</td><td>31/37</td></tr><tr><td colspan="4">Bacterial isolation site</td></tr><tr><td> Blood</td><td>20 (90.9%)</td... |
cefdb1d1feef78547c912d78cbc4669a0958556873324c35c26eea09e725862f.png | complex | <table><tr><td>Session</td><td>Depression-specific topics</td><td>Diabetes-specific topics added</td></tr><tr><td>1</td><td>Psychoeducation</td><td>Connection diabetes and depression</td></tr><tr><td>2</td><td>Behavioural activation</td><td>Worrying about diabetes-related complications</td></tr><tr><td>3</td><td>Proble... |
a85fddf5f5893cf09fa1c4e9baca83c1c2aebcee2f4897c8e3c08c5b57b95f02.png | simple | <table><tr><td></td><td>Applied in specialty</td><td>Auditioned in specialty</td><td>% matched at audition (<i>n</i>)</td></tr><tr><td>Radiation oncology</td><td>5</td><td>5</td><td>80 (4)</td></tr><tr><td>PM&R</td><td>6</td><td>5</td><td>60 (3)</td></tr><tr><td>Orthopedics</td><td>33</td><td>31</td><td>58 (18)</td... |
308c5c07ae734dc21a2df855aac9104b150d72bb4f620af29db693d4b91ae282.png | complex | <table><tr><td>Total CAS Score</td><td colspan="3">Rating of Intervention Effectiveness</td><td>Total No. Studies with each CAS Score</td></tr><tr><td></td><td>0</td><td>0.5</td><td>1</td><td></td></tr><tr><td>0</td><td>1</td><td>0</td><td>0</td><td>1</td></tr><tr><td>1</td><td>1</td><td>1</td><td>0</td><td>2</td></tr>... |
469474a708c79fb540938fe08769e47e31df9ebaaf37ad7ddd92f5bf13c8a5d3.png | simple | <table><tr><td><i>Characteristics</i></td><td><i>Number of patients</i></td><td><i>%</i></td></tr><tr><td>Total analyzed</td><td>149</td><td></td></tr><tr><td>Sex</td><td></td><td></td></tr><tr><td> Males</td><td>59</td><td><i>40</i></td></tr><tr><td> Females</td><td>90</td><td><i>60</i></td></tr><tr><td>Median Age (ye... |
63ed70baae849ef97d76f97f6de759699d988e6f5f225423f76624b7b7b42dc9.png | simple | <table><tr><td>Laboratory tests</td><td>result</td><td>Normal range</td></tr><tr><td>K</td><td>5.2</td><td>3.4–5.3 mmol /L</td></tr><tr><td>Na</td><td>137</td><td>137–147 mmol /L</td></tr><tr><td>Cl</td><td>102</td><td>99–108 mmol /L</td></tr><tr><td>Ca</td><td>9.5</td><td>8.7–10.7 mg /dL</td></... |
75a13a7ca7cf4a9ce8ef43dbad9fccd993d848ecc23a37808461f7e1b3ccbb09.png | complex | <table><tr><td rowspan="2">Characteristics</td><td rowspan="2">Females (number)</td><td rowspan="2">Age (years)</td><td rowspan="2">Duration of symptoms (months)</td><td rowspan="2">Symptoms preceeding malignancy (number)</td><td colspan="2">Malignancy</td></tr><tr><td>All tumors (number)</td><td>Lung cancer (number)</... |
b90beb76bed1b796a9adc8e5c01d75822163e0e0cef26ae2be9601ea62afb303.png | simple | <table><tr><td>Attribute</td><td>Value</td><td>% of Total</td></tr><tr><td>Genome size (bp)</td><td>3,086,721</td><td>100.00</td></tr><tr><td>DNA coding (bp)</td><td>2,284,152</td><td>74.00</td></tr><tr><td>DNA G+C (bp)</td><td>2,147,191</td><td>69.56</td></tr><tr><td>DNA scaffolds</td><td>109</td><td></td></tr><tr><td... |
2098576e6c9cd080e0ed42420e36f2dda5a995350f4ff2157b4ac04cc51774bf.png | simple | <table><tr><td>Dependent variable in all regressions: IHD mortality</td><td>Adjusting for Beef Consumption</td><td>Adjusting for Coconut Oil Consumption</td><td>Adjusting for Milk Consumption</td><td>Adjusting for Butter Consumption</td><td>Adjusting for Cheese Consumption</td><td>Adjusting for Pork Consumption</td><td... |
041f8d1a3b62f50bcc31c1c07cdff9a5cf0ecca3cbdbb62fb8a4a197da3d297b.png | simple | <table><tr><td> </td><td>PE patients</td><td>DVT patients</td></tr><tr><td> </td><td>(n=305)</td><td>(n=138)</td></tr><tr><td>Fatal pulmonary embolism</td><td>76 (24.9%)</td><td>6 (4.3%)</td></tr><tr><td>Respiratory insufficiency</td><td>55 (18.0%)</td><td>22 (15.9%)</td></tr><tr><td>Neoplasia</td><td>44 (14.4%)</td><t... |
a0868dc6d932efb0c7092a7e2f5f1d21d034f9e00733982f4837634f3a5cbe31.png | simple | <table><tr><td>Characteristics</td><td>n</td><td>%</td></tr><tr><td>Age (y)</td><td></td><td></td></tr><tr><td>≤35</td><td>110</td><td>10.7</td></tr><tr><td>36–50</td><td>527</td><td>51.1</td></tr><tr><td>>50</td><td>395</td><td>38.3</td></tr><tr><td>cT stage</td><td></td><td></td></tr><tr><td>T1</td><td... |
66f553d8ac612c6fa4fe96ab47196c634463b431b9a19824ca4fcd1e0a4c756c.png | complex | <table><tr><td></td><td colspan="3">Perceived general health ('excellent/very good/good' = 1)</td></tr><tr><td></td><td>Model 1a</td><td>Model 1b</td><td>Model 2</td></tr><tr><td>% of green (1 km)</td><td>.010 (.003) [p = .002]</td><td>.011 (.003) [p = .005]</td><td></td></tr><tr><td>% of green (3 km)</td><td></td><td>... |
3c4fb765b10e353d80516ec91f8578d76eb445c4fcf5a1a3eb6b6d8831da374f.png | complex | <table><tr><td></td><td>Rice</td><td></td><td></td><td><i>Arabidopsis</i></td><td></td></tr><tr><td>Groups</td><td>Tissues</td><td>Genes</td><td>Groups</td><td>Tissues</td><td>Genes</td></tr><tr><td colspan="3"><i>Preferential expression in young vegetative tissues</i></td><td></td><td></td><td></td></tr><tr><td>IA</td... |
ecb560c6b7be212f631835ebc3c2ceaf528e9b177d582e8478ef997eb7c0d787.png | simple | <table><tr><td>Classification Algorithm</td><td>Acronym</td></tr><tr><td>Fisher Discriminant Analysis</td><td>FDA</td></tr><tr><td>Fuzzy Min-Max Neural Network</td><td>FMMNN</td></tr><tr><td>Kernel Linear Discriminant Analysis</td><td>GK-FDA</td></tr><tr><td>Kernel Support Vector Machine</td><td>GK-SVM</td></tr><tr><td... |
380c741aa1d16c4746f6a3a7da1fe360ed837309fe9ee7cb319fe75fc2e766f8.png | simple | <table><tr><td>Target</td><td><i>cyp19a2</i>-1</td><td><i>vasa</i>-3</td><td><i>vasa</i>-5</td><td><i>vtg1</i>-3</td></tr><tr><td>effect</td><td>-/↑ 164</td><td>↑ 61.6/-</td><td>↑ 143/-</td><td>-/↑ 74.7</td></tr></table> |
058f0df5a01c81270d2625ba5fe74e42c3f2ed95c40160f5a4a62b127482b0ed.png | complex | <table><tr><td></td><td colspan="2">PlateliaTM Dengue NS1 Ag-ELISA</td><td>Sensitivity(95% CI)</td><td><i>p</i>-value</td></tr><tr><td rowspan="2">Overall sensitivity</td><td colspan="2">Non-dissociated</td><td>47.8(39.3 – 56.4)</td><td rowspan="2"><i>p</i> < 0.001</td></tr><tr><td colspan="2">Heat dissociated... |
3522ca8a6bf827fb7bf70e85c72001afab0df344ee4286abfdc62befd40256ac.png | complex | <table><tr><td>Assemblathon metrics</td><td>RJ</td><td>SGA</td><td>Edena</td><td>LEAP</td></tr><tr><td>Number of contigs</td><td>120712</td><td>231594</td><td>120462</td><td>113428</td></tr><tr><td>Genome size (bp)</td><td>34894545</td><td>34894545</td><td>34894545</td><td>34894545</td></tr><tr><td>Total contigs length... |
9e643438a9598c3dc06f1c0a5e6762fc4d0fff6796e877161cb8447cc3c84520.png | simple | <table><tr><td>Groups</td><td>VT</td><td>AF</td></tr><tr><td>sham (n=5)</td><td>0</td><td>0</td></tr><tr><td>t-AUCB(5 mg/L)+ sham (n=5)</td><td>0</td><td>0</td></tr><tr><td>MI (n=10)</td><td>7(70%)<sup>*</sup></td><td>3(30%)<sup>*</sup></td></tr><tr><td>t-AUCB(0.2 mg/L) + MI (n=5)</td><td>3(60%)</td><td>1(20%)</td></tr... |
fa4ca662e0b941c8ae4fea64053c63b840502c39ab242b1cb79edd20b998a599.png | simple | <table><tr><td>Population</td><td>Sample size</td><td>Sampling location</td><td>Longitude and latitude</td></tr><tr><td></td><td>90</td><td>Minqing County, Fujian Province,</td><td>118.3, 25.6</td></tr><tr><td>Han</td><td>95</td><td>Chengdu City, Sichuan Province,</td><td>104.1, 30.6</td></tr><tr><td></td><td>30</td><t... |
204e0b617fc2b49f746fb7cd377faea18a8cc63c298aedef7aed6b88b2ccaa8a.png | complex | <table><tr><td rowspan="2">Cost</td><td rowspan="2">Parameter</td><td colspan="2">Overall cost of treatment</td><td rowspan="2">Proportion of total cost</td></tr><tr><td>Average</td><td>SD</td></tr><tr><td rowspan="6">Direct Medical</td><td>Diagnostic</td><td>37.63 (0.48)</td><td>189.71 (2.42)</td><td rowspan="6">28</t... |
953921be287a988f884fc0feee040f3dc73700adc002abf8a545b5802c5ee3c2.png | complex | <table><tr><td rowspan="2">Variants Coding</td><td colspan="4">Log Reduction</td></tr><tr><td><i>P. fluorescens</i></td><td><i>Y. enterocolitica</i></td><td><i>B. cereus</i></td><td><i>S. aureus</i></td></tr><tr><td>C0<i>T</i>0</td><td>2.2 ± 0.26</td><td>0.3 ± 0.13</td><td>9.2 ± 0.06</td><td>0.9 ± 0... |
5fe4bbee04afb5ffd290bf8efacff459263bb490ff54c621e606b6282d3ae35a.png | complex | <table><tr><td rowspan="2">Author</td><td rowspan="2">N</td><td>PD-L1 (%)</td><td>Histology (%)</td><td>Stage (%)</td><td rowspan="2">Correlation withPD-L1 positive</td><td rowspan="2">Prognosis ofPD-L1 positive</td></tr><tr><td>1-49%/ >50%</td><td>ADs/Sq/others</td><td>I/II/III/IV</td></tr><tr><td>Reck M<sup>1</sup... |
28309125322f1493ca4c5f517b1e8b60e9ac7e71b69e94f46a43e3e7667ca4e4.png | complex | <table><tr><td></td><td>Total population (n = 257)</td><td>SR-group(n = 148)</td><td>AF-group (n = 109)</td><td><i>p</i> Value</td><td>OR (95% CI)</td></tr><tr><td colspan="6">Follow-up Minor vascular complication</td></tr><tr><td> 30 days</td><td>22.6% (58/257)</td><td>22.3% (33/148)</td><td>22.9% (25/109)</td><td>1.0... |
2c8cd753507bb7155a98b8a0d957a57525bda82689b32c3db0f9bbf575163571.png | complex | <table><tr><td>Genotype</td><td>Actual Values</td><td>Expected Value</td><td>χ<sup>2</sup></td><td><i>p</i></td></tr><tr><td>T102C</td><td></td><td></td><td></td><td></td></tr><tr><td>TT</td><td>108</td><td>120.95</td><td rowspan="3">3.589</td><td rowspan="3">0.166</td></tr><tr><td>TC</td><td>194</td><td>169.33</t... |
9cefbd7905ff11b3f4d7229a218847e1604a7e9f8315f6be70f5a8295fac00f9.png | complex | <table><tr><td rowspan="2">Risk factors</td><td>Univariate</td><td colspan="3">Multivariate</td></tr><tr><td>P-value</td><td>RR</td><td>95%CI</td><td>P-value</td></tr><tr><td>Age, ≤60 vs. >60 years</td><td><i>0.006*</i></td><td></td><td></td><td>0.763</td></tr><tr><td>Gender, male vs. female</td><td>0.24</td><... |
80ee3b0356fdc14f5eec0dd317ab8c3dba1581077fbea9b7f0447bfafd206f72.png | simple | <table><tr><td> </td><td>AE</td><td>CE</td><td>FW</td></tr><tr><td>Total drink volume (mL)</td><td>2292.25 ± 457.99</td><td>2279.26 ± 483.63</td><td>2360.44 ± 519.75</td></tr><tr><td>Test drink volume (mL)</td><td>772.46 ± 93.17</td><td>774.73 ± 100.9</td><td>770.83 ± 96.88</td></tr><tr><t... |
5c858155c2f492c74ab68b7603fbe3e281354fbf5791743535d1fe156ad92564.png | simple | <table><tr><td>Index</td><td>Group</td><td>0-week</td><td>2-week</td><td>4-week</td><td>8-week</td><td>12-week</td></tr><tr><td>TC</td><td>NDG</td><td>1.67 ± 0.43</td><td>1.72 ± 0.45</td><td>1.72 ± 0.25</td><td>1.98 ± 0.55</td><td>2.02 ± 0.58</td></tr><tr><td></td><td>HH</td><td>1.80 ± 0.2... |
1fc3fab7cbcd8a97d285980ef10c82a0432d32637638c7e2188bfc5dfb1fa0d5.png | complex | <table><tr><td>Subtheme</td><td>Quote</td></tr><tr><td rowspan="3">Previous experiences with teletraining</td><td>“What I actually find more useful [in Rural Grand Rounds] is quite often he gets paediatricians, emergency medicine from [bigger regional centres], from everywhere who actually do speeches and talks&#... |
dc8b05760a67db0b62ac0514a1c48545968186a75d52fb62f3d7fb54ef8d3e84.png | complex | <table><tr><td></td><td colspan="6">Emotive coping</td></tr><tr><td></td><td colspan="3">Univariate</td><td colspan="3">Multivariate<sup>a</sup></td></tr><tr><td>Variables</td><td>OR</td><td>(95% CI)</td><td><i>p</i>-value</td><td>OR</td><td>(95% CI)</td><td><i>p</i>-value</td></tr><tr><td>Sex (female)</td><td>4.07</td... |
5bcce8edc20138dce1922ef0575e0f09debdc71e80fef5c40fadffa075af64cf.png | simple | <table><tr><td>Characteristic</td><td>N</td><td>%</td></tr><tr><td>Age (Years)</td><td> </td><td> </td></tr><tr><td> <40</td><td>39</td><td>5.6</td></tr><tr><td> 40-49</td><td>165</td><td>23.7</td></tr><tr><td> 50-59</td><td>215</td><td>30.9</td></tr><tr><td> 60-69</td><td>214</td><td>30.8</td></tr><tr><td> 70+</td>... |
13e6c96ed7357bd1433cb2ecb1d9d21a1805406019daa7643a8791e8f78cc4ea.png | complex | <table><tr><td rowspan="2"> </td><td colspan="2">Adult learning disability</td><td colspan="2">Head and neck cancer</td><td colspan="2">Other</td></tr><tr><td>Non aspiration pneumonia</td><td>Aspiration pneumonia</td><td>Non aspiration pneumonia</td><td>Aspiration pneumonia</td><td>Non aspiration pneumonia</td><td>Aspi... |
5445734146b66ac9e2a036dfa1e37525119547d91682724fc04d70ec9448bf2d.png | complex | <table><tr><td rowspan="2">Characteristics</td><td>PE factor</td><td>DE factor</td><td>NC factor</td><td>PS factor</td><td>NE factor</td><td>CS factor</td></tr><tr><td>Mean (SD)</td><td>Mean (SD)</td><td>Mean (SD)</td><td>Mean (SD)</td><td>Mean (SD)</td><td>Mean (SD)</td></tr><tr><td colspan="7">Residential area</td></... |
d42c5cbd385ab20c8ef99f4713813a989e001ba00e8941ab90b2c7de18a13a2f.png | simple | <table><tr><td>Clinical/Laboratory/ Radiological Finding</td><td>Specification</td></tr><tr><td>Impaired consciousness or unrousable coma</td><td>Glasgow Coma Scale ≤10<sup>b</sup></td></tr><tr><td>Multiple convulsions</td><td>>2 episodes within 24 h or generalized seizures</td></tr><tr><td>Respiratory distres... |
1d3ecc78edc256c5e941cb9fb21b8c5f0b25a93c037bcbd54a74ec4d4b975b35.png | complex | <table><tr><td></td><td></td><td colspan="4"><i>T</i><sub>1</sub></td></tr><tr><td></td><td></td><td>Excellent/very good <i>N</i> (%)</td><td>Good <i>N</i> (%)</td><td>Fair/poor <i>N</i> (%)</td><td>Total<i>N</i> (%)</td></tr><tr><td rowspan="3"><i>T</i><sub>0</sub></td><td> Excellent/very good</td><td>142 (19.7)</td><... |
f8cc386b3a7c2abd7f2892fba63d98433611856b045fdefb8383379bbbeec21d.png | simple | <table><tr><td></td><td>Lab studies</td><td>Outdoor studies</td></tr><tr><td>1980-1985</td><td>Collection & screening of algae</td><td>Wastewater treatment, small pond studies</td></tr><tr><td>1985-1990</td><td>Classification of algae biochemistry & physiology of lipid production</td><td>Large pond studies</td>... |
c73cb04c0b51040c750ecd6f5c7f7ae991bfb97f322e74fbe15acef26eb5261c.png | complex | <table><tr><td>Age group (years)</td><td colspan="2">Male</td><td colspan="2">Female</td><td colspan="2">Total</td></tr><tr><td colspan="7">Levels of Systolic Blood Pressure (SBP) in different age groups (mmHg, median (Q25; Q75)</td></tr><tr><td></td><td>SBP</td><td>Q25; Q75</td><td>SBP</td><td>Q25; Q75</td><td>SBP</td... |
5412f577846f774779f8fb6500505ed702147296dbdd1de679c3cebfb96ffdbe.png | complex | <table><tr><td></td><td colspan="3">PCI</td><td colspan="3">CABG</td><td colspan="3">PCI and/or CABG</td></tr><tr><td>State</td><td>No. of Cases</td><td>Rate</td><td>Ratio to Mean (95% CI)</td><td>No. of Cases</td><td>Rate</td><td>Ratio to Mean (95% CI)</td><td>No. of Cases</td><td>Rate</td><td>Ratio to Mean (95% CI)</... |
269a358a1e6931b12a5aba40ae57f05556aad6e948260d577fe6b7a875e4151d.png | simple | <table><tr><td>Number</td><td>Vitamin E succinate (%)</td><td>Vitamin E acetate (%)</td><td>Gamma- tocopheryl succinate(%)</td></tr><tr><td>1</td><td>112.5 ± 8.4</td><td> 0</td><td>0.38</td></tr><tr><td>2</td><td>116.9 ± 8.3</td><td> 0</td><td>0.46</td></tr><tr><td>3</td><td>104.2 ± 9.7</td><td> 0</td><t... |
649f4cce1b3b969f5a3ca8706415fb523644e095caa029a648fd483726338a1e.png | complex | <table><tr><td></td><td colspan="3">Trimmed population</td><td colspan="3">Stratified-matched population</td></tr><tr><td></td><td>Rituximab (<i>n</i> = 265)</td><td>Anti-TNF (<i>n</i> = 737)</td><td>Standardized difference</td><td>Rituximab(<i>n</i> = 205)</td><td>Anti-TNF(<i>n</i> = 205)</td><td>Standardized differen... |
9284a9c190b12c11842ebc465c6a2c42bed826b91a02f11c7364cc5f676374c6.png | complex | <table><tr><td>Gene Family Member</td><td colspan="2">Enriched Genes</td><td colspan="2">Cases</td><td colspan="2">Controls</td><td colspan="3">Gene Network Association</td></tr><tr><td> </td><td>No.</td><td>Frequency</td><td>No.</td><td>Frequency</td><td>#</td><td>Frequency</td><td><i>P</i><sub>fisher</sub></td><td>En... |
5421d082d4d893502ce17cb4ed2e2044a8ab3d1827b16875fb84f61d5a10d4ad.png | complex | <table><tr><td rowspan="2">LA responses (mmol.L<sup>−1</sup>)</td><td>Pre-RF</td><td>Beg-RF</td><td>End-RF</td><td>After-RF</td><td>F</td><td>p</td></tr><tr><td>Resting LA</td><td>1.27±0.33</td><td>1.11±0.28</td><td>1.18±0.30</td><td>1.12±0.37</td><td>1.45</td><td>0.240</td></tr><tr><td>LA at ... |
cd68cab4819dbe3fc5083f56ffa05f2a77efa57711f2bd7c8da58ce91644792d.png | simple | <table><tr><td>Primer name</td><td>Direction</td><td>Nucleotide sequence (5' to 3')</td></tr><tr><td>KSC138-9</td><td>Forward</td><td>GCACAATAAATTGGGCCTGA</td></tr><tr><td></td><td>Reverse</td><td>GCGAGTGTTGGGCTAAGTCT</td></tr><tr><td>KSC138-10</td><td>Forward</td><td>CACGAATGTGAATTTGATCG</td></tr><tr><td></td><td>Reve... |
a6ddd4234d88598c775f3aa8adea5a6be14ec6450b1b351e4f4b2edefef9f91b.png | complex | <table><tr><td>Decoy</td><td>RNA</td><td>Length</td><td>Method</td><td colspan="4">Enrichment score (RMSD)</td><td colspan="4">Enrichment score (DI)</td></tr><tr><td></td><td></td><td></td><td></td><td>3dRNAscore</td><td>KB</td><td>RASP</td><td>Rosetta</td><td>3dRNAscore</td><td>KB</td><td>RASP</td><td>Rosetta</td></tr... |
1d794f49459200fcd9aa0120dfef9053c8587997a3093cb9a79602ed9d6f47e4.png | complex | <table><tr><td></td><td colspan="4">Mumias (Control site)</td><td colspan="4">Butere (intervention site)</td></tr><tr><td>Health indicator</td><td>Baseline</td><td>Endline</td><td>Change</td><td><i>p</i>-value</td><td>Baseline</td><td>Endline</td><td>Change</td><td><i>p</i>-value</td></tr><tr><td>ANC</td><td>66.3</td><... |
cf1c183844920da4233612cd045fe94001a9ce1724c615eabde5f2751ec1fbd6.png | complex | <table><tr><td>Databases</td><td>PubMed</td><td>Embase</td><td>CINAHL</td></tr><tr><td>(“Saudi Arabia”[MeSH]) AND “Diabetes Mellitus, Type 2” [MeSH]</td><td>114 (76), Ex: 38 (date range)</td><td>1015 (853) Ex: 162 (DR)</td><td>20 (20) Ex: 0 (DR)</td></tr><tr><td>(“Referral and Consultation... |
ad851522fe066085f11cb83fb4e8c2421267a9fb116c655359d9386ccb6501a0.png | simple | <table><tr><td>Exercise</td><td>Dosage</td></tr><tr><td>Abduction in sidelying</td><td>3 sets of 10 at a 10 RM resistance</td></tr><tr><td> Unilateral hip abduction performed in sidelying with the use of ankle cuff weights</td><td></td></tr><tr><td>Abduction in standing</td><td>3 sets of 10 with moderate resistance ban... |
63d7cd8f268eaa6e413e9727797fa158e93c4648e4674e8263e7337b27b1d0bd.png | complex | <table><tr><td>Study</td><td>Genotype</td><td>Sex</td><td>N</td><td>Key Experimental Outcomes</td></tr><tr><td rowspan="6">Epithelial CellProliferation</td><td rowspan="3">WT</td><td>Both</td><td>14</td><td rowspan="6">In <i>Fgf15</i><sup><i>-/-</i></sup> mice, we detected a shift of proliferating cells to upper crypt ... |
ef2fea18c17e56694b7adccab7328709ad849d29e1a18abdc1c71428cd69d83e.png | simple | <table><tr><td>Item</td><td>Person-time</td><td>%</td></tr><tr><td>Utilization of health services</td><td></td><td></td></tr><tr><td> Saw a doctor</td><td>118</td><td>36.4</td></tr><tr><td> Self-medication</td><td>108</td><td>33.3</td></tr><tr><td> Non use</td><td>98</td><td>30.3</td></tr><tr><td> Total</td><td>324</td... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.